Renouf D - Search Results

1

Capecitabine-induced cerebellar toxicity.

Renouf D, Gill S. Renouf D, et al. Clin Colorectal Cancer. 2006 May;6(1):70-1. doi: 10.3816/CCC.2006.n.024. Clin Colorectal Cancer. 2006. PMID: 16796795

2

Trends in chemotherapy utilization for colorectal cancer.

Renouf D, Kennecke H, Gill S. Renouf D, et al. Clin Colorectal Cancer. 2008 Nov;7(6):386-9. doi: 10.3816/CCC.2008.n.051. Clin Colorectal Cancer. 2008. PMID: 19036691

3

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.

Renouf DJ, Moore MJ, Hedley D, Gill S, Jonker D, Chen E, Walde D, Goel R, Southwood B, Gauthier I, Walsh W, McIntosh L, Seymour L. Renouf DJ, et al. Invest New Drugs. 2012 Apr;30(2):779-86. doi: 10.1007/s10637-010-9611-3. Epub 2010 Dec 18. Invest New Drugs. 2012. PMID: 21170669 Clinical Trial.

4

Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.

Renouf DJ, Lim HJ, Speers C, Villa D, Gill S, Blanke CD, O'Reilly SE, Kennecke H. Renouf DJ, et al. Clin Colorectal Cancer. 2011 Jun;10(2):97-101. doi: 10.1016/j.clcc.2011.03.004. Epub 2011 Apr 22. Clin Colorectal Cancer. 2011. PMID: 21859560

5

A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer.

Renouf DJ, Welch S, Moore MJ, Krzyzanowska MK, Knox J, Feld R, Liu G, MacKay H, Petronis J, Wang L, Chen E. Renouf DJ, et al. Cancer Chemother Pharmacol. 2012 May;69(5):1339-44. doi: 10.1007/s00280-012-1843-9. Epub 2012 Feb 15. Cancer Chemother Pharmacol. 2012. PMID: 22349811 Clinical Trial.

6

Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer.

Alipour S, Kennecke HF, Woods R, Lim HJ, Speers C, Brown CJ, Gill S, Renouf DJ, Cheung WY. Alipour S, et al. J Gastrointest Cancer. 2013 Jun;44(2):203-10. doi: 10.1007/s12029-012-9472-4. J Gastrointest Cancer. 2013. PMID: 23264206

7

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.

Renouf DJ, Tang PA, Hedley D, Chen E, Kamel-Reid S, Tsao MS, Tran-Thanh D, Gill S, Dhani N, Au HJ, Wang L, Moore MJ. Renouf DJ, et al. Eur J Cancer. 2014 Jul;50(11):1909-15. doi: 10.1016/j.ejca.2014.04.008. Epub 2014 May 21. Eur J Cancer. 2014. PMID: 24857345 Clinical Trial.

8

Relationship of ethnicity and overall survival in patients treated with sorafenib for advanced hepatocellular carcinoma.

Peixoto RD, Renouf DJ, Gill S, Cheung WY, Lim HJ. Peixoto RD, et al. Among authors: renouf dj. J Gastrointest Oncol. 2014 Aug;5(4):259-64. doi: 10.3978/j.issn.2078-6891.2014.036. J Gastrointest Oncol. 2014. PMID: 25083298 Free PMC article.

9

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.

Kumar A, Kennecke HF, Renouf DJ, Lim HJ, Gill S, Woods R, Speers C, Cheung WY. Kumar A, et al. Cancer. 2015 Feb 15;121(4):527-34. doi: 10.1002/cncr.29072. Epub 2014 Oct 20. Cancer. 2015. PMID: 25332117 Free article.

10

Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.

Peixoto RD, Kumar A, Speers C, Renouf D, Kennecke HF, Lim HJ, Cheung WY, Melosky B, Gill S. Peixoto RD, et al. Among authors: renouf d. Clin Colorectal Cancer. 2015 Mar;14(1):25-30. doi: 10.1016/j.clcc.2014.10.002. Epub 2014 Nov 4. Clin Colorectal Cancer. 2015. PMID: 25465343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

195 results

Search Page

Filters